Clinical Trial Update: COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS) [Phase 2]

View source ↗

Summary

COLOR-ACS is a Phase 2 trial investigating colchicine given on admission to reduce inflammation in non-ST elevation acute coronary syndrome, and the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Acute Coronary Syndrome

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Azienda USL Toscana Centro | Conditions: Non ST Segment Elevation Acute Coronary Syndrome | Phase 2 | Status: COMPLETED